Neuromeka Subsidiary Rovolution Secures KRW 2 Billion in Pre-Series A Funding…“Growth Driven by Robot Platform Foundry Model”

Rovolution, a two-year-old company, has gained market recognition for its growth potential despite its short operating history. Leveraging its technological capabilities in industrial robots and manufacturing process automation, the company has accumulated project experience with major players such as HD Hyundai Robotics, NAVER LABS, LG Display, and Samsung Display.

Rovolution’s core competitive advantage lies in its full-cycle robot value chain, encompassing robot manufacturing, solution integration, and overhaul services (robot disassembly, precision inspection, and refurbishment). Building on its accumulated expertise in industrial robots and large-scale manufacturing automation, the company plans to develop next-generation robots for manufacturing facilities that emphasize high precision and reliability, while pursuing phased commercialization. Through this strategy, Rovolution aims to expand its customer base across a wide range of manufacturing industries.

In addition, through collaboration with its parent company Neuromeka, Rovolution is establishing a robot manufacturing foundry model based on Manufacturing as a Service (MaaS). This integrated structure provides end-to-end services covering robot design, prototyping, and mass production. Currently, the company operates production bases in Changwon, Gyeongnam Province, and Pohang, Gyeongbuk Province, and is reviewing plans to further advance its smart manufacturing infrastructure in preparation for increased demand.

To strengthen its robot manufacturing capabilities, Rovolution has strategically secured skilled personnel and facilities while internalizing its production base. Building on this foundation, the company is expanding its product portfolio beyond the display industry into automotive, logistics, and medical sectors, with discussions underway regarding potential follow-on investments.

Park Jong-hoon, CEO of Rovolution, stated, “We have grown rapidly by validating our robot manufacturing capabilities and supply capacity across various industrial sites. With this investment, we will further strengthen our manufacturing system centered on our new Changwon facility and aim to achieve break-even (BEP) by 2026, fully materializing our business performance.”

Gyeongnam Venture Investment, the investor, commented, “Rovolution is a company that combines strong robot technology based on industry-specific domain expertise with cost competitiveness and robot manufacturing foundry capabilities. We expect this investment to contribute positively not only to Rovolution’s growth but also to the overall corporate value of the Neuromeka Group.”